Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,accountsPayable,changeToLiabilities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,changeToNetincome,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,priceHint,regularMarketChangePercent,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,currency,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,shortName,exchangeDataDelayedBy,market,marketState,twoHundredDayAverageChangePercent,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,ISCNF,4078250,143164992,,,-1662759,-3291,-1670679,1878826,0,-1888574,-1888574,,,,,,0,0,1888574,0,225815,-7920,-1662759,-1670679,20619194,1115706,24697444,534774,25809859,60813311,291256,-50427764,14311897,1837223,2316826,1115706,14311897,87734,3002346,263362,317574,455303,165285.0,1252644.0,27680.0,1252644.0,294747.0,-719.0,-957178.0,9748.0,-40685.0,551473.0,,1886640,en-US,US,EQUITY,False,Delayed Quote,421228,0.019000001,0.2585034,0.0735 - 0.351,-0.2585,-0.73646724,0.0735,0.351,1571270400,0.12702857,-0.03452857,-0.27181736,0.20273913,-0.11023913,13292620,4,15.3366585,15,America/New_York,EDT,-14400000,0.0735 - 0.0952,0.0802,finmb_586349685,Other OTC,Isracann Biosciences Inc.,CAD,304850,USD,False,False,0.0925,1630525392,0.0123,0.0735,0.0952,0.0735,284999,PNK,ISRACANN BIOSCIENCES INC,0,us_market,PRE,-0.5437487,,,,0.351,0.0735,0.127,0.2027,304.85k,421.23k,143.16M,,136.45M,0.17%,0.03%,,,,,,,,,,,0.00%,"Oct 16, 2019",,1:3,"Oct 16, 2019","May 30, 2020","Feb 27, 2021",0.00%,"8,564.67%",-11.60%,-53.57%,-81.42k,-0.00,,,-6.93M,-19.51M,,,2.32M,0.02,,,2.69,,-4.41M,-2.13M,Value,V7X 1L3,Healthcare,"Isracann Biosciences Inc., together with its subsidiaries, cultivates, produces, and distributes medical cannabis in Israel. The company also provides construction of cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",Vancouver,604 394 2551,BC,1577750400,Canada,http://www.isracann.com,86400,595 Burrard Street,Drug Manufacturers—Specialty & Generic,Suite 1600
t-1,ISCNF,3827787,143164992,,,-1342995,-3291,-1351603,1070555,0,-1080304,-1080304,,,,,,0,0,1080304,0,-262691,-8608,-1342995,-1351603,20619194,957100,24446981,541453,25400790,57332841,304770,-46039695,13153835,1873799,2022079,957100,13153835,97483,2542088,268226,110869,338072,-247701.0,3550.0,83654.0,1252644.0,-1277434.0,-106.0,-1280878.0,9749.0,183202.0,73082.0,3550.0,1584988,en-US,US,EQUITY,False,Delayed Quote,421228,0.019000001,0.2585034,0.0735 - 0.351,-0.2585,-0.73646724,0.0735,0.351,1571270400,0.12702857,-0.03452857,-0.27181736,0.20273913,-0.11023913,13292620,4,15.3366585,15,America/New_York,EDT,-14400000,0.0735 - 0.0952,0.0802,finmb_586349685,Other OTC,Isracann Biosciences Inc.,CAD,304850,USD,False,False,0.0925,1630525392,0.0123,0.0735,0.0952,0.0735,284999,PNK,ISRACANN BIOSCIENCES INC,0,us_market,PRE,-0.5437487,,,,0.351,0.0735,0.127,0.2027,304.85k,421.23k,143.16M,,136.45M,0.17%,0.03%,,,,,,,,,,,0.00%,"Oct 16, 2019",,1:3,"Oct 16, 2019","May 30, 2020","Feb 27, 2021",0.00%,"8,564.67%",-11.60%,-53.57%,-81.42k,-0.00,,,-6.93M,-19.51M,,,2.32M,0.02,,,2.69,,-4.41M,-2.13M,Value,V7X 1L3,Healthcare,"Isracann Biosciences Inc., together with its subsidiaries, cultivates, produces, and distributes medical cannabis in Israel. The company also provides construction of cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",Vancouver,604 394 2551,BC,1577750400,Canada,http://www.isracann.com,86400,595 Burrard Street,Drug Manufacturers—Specialty & Generic,Suite 1600
t-2,ISCNF,5190973,143164992,,,-838792,-3291,-870943,836852,0,-846685,-846685,,,,,,0,0,846685,0,7893,-32151,-838792,-870943,20619194,1207022,25810167,543674,27013898,57332841,314878,-44656831,13134157,1775260,3299513,1207022,13134157,107231,4245380,266833,442965,595875,79633.0,131792.0,-9796.0,70113.0,-591470.0,-106.0,-723262.0,9833.0,-187305.0,255316.0,61679.0,3038358,en-US,US,EQUITY,False,Delayed Quote,421228,0.019000001,0.2585034,0.0735 - 0.351,-0.2585,-0.73646724,0.0735,0.351,1571270400,0.12702857,-0.03452857,-0.27181736,0.20273913,-0.11023913,13292620,4,15.3366585,15,America/New_York,EDT,-14400000,0.0735 - 0.0952,0.0802,finmb_586349685,Other OTC,Isracann Biosciences Inc.,CAD,304850,USD,False,False,0.0925,1630525392,0.0123,0.0735,0.0952,0.0735,284999,PNK,ISRACANN BIOSCIENCES INC,0,us_market,PRE,-0.5437487,,,,0.351,0.0735,0.127,0.2027,304.85k,421.23k,143.16M,,136.45M,0.17%,0.03%,,,,,,,,,,,0.00%,"Oct 16, 2019",,1:3,"Oct 16, 2019","May 30, 2020","Feb 27, 2021",0.00%,"8,564.67%",-11.60%,-53.57%,-81.42k,-0.00,,,-6.93M,-19.51M,,,2.32M,0.02,,,2.69,,-4.41M,-2.13M,Value,V7X 1L3,Healthcare,"Isracann Biosciences Inc., together with its subsidiaries, cultivates, produces, and distributes medical cannabis in Israel. The company also provides construction of cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",Vancouver,604 394 2551,BC,1577750400,Canada,http://www.isracann.com,86400,595 Burrard Street,Drug Manufacturers—Specialty & Generic,Suite 1600
t-3,ISCNF,5939709,143164992,,,-838792,-3291,0,836852,0,0,-846685,,,,,,0,0,0,0,0,-32151,-838792,-870943,20619194,1718433,26558903,967218,28274045,56893818,1165966,-43785888,13450973,1790595,3890983,1718433,13450973,117064,5478054,269138,242877,705033,0.0,131792.0,-9796.0,70113.0,-591470.0,-106.0,-723262.0,9833.0,-187305.0,255316.0,61679.0,3759621,en-US,US,EQUITY,False,Delayed Quote,421228,0.019000001,0.2585034,0.0735 - 0.351,-0.2585,-0.73646724,0.0735,0.351,1571270400,0.12702857,-0.03452857,-0.27181736,0.20273913,-0.11023913,13292620,4,15.3366585,15,America/New_York,EDT,-14400000,0.0735 - 0.0952,0.0802,finmb_586349685,Other OTC,Isracann Biosciences Inc.,CAD,304850,USD,False,False,0.0925,1630525392,0.0123,0.0735,0.0952,0.0735,284999,PNK,ISRACANN BIOSCIENCES INC,0,us_market,PRE,-0.5437487,,,,0.351,0.0735,0.127,0.2027,304.85k,421.23k,143.16M,,136.45M,0.17%,0.03%,,,,,,,,,,,0.00%,"Oct 16, 2019",,1:3,"Oct 16, 2019","May 30, 2020","Feb 27, 2021",0.00%,"8,564.67%",-11.60%,-53.57%,-81.42k,-0.00,,,-6.93M,-19.51M,,,2.32M,0.02,,,2.69,,-4.41M,-2.13M,Value,V7X 1L3,Healthcare,"Isracann Biosciences Inc., together with its subsidiaries, cultivates, produces, and distributes medical cannabis in Israel. The company also provides construction of cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.",Vancouver,604 394 2551,BC,1577750400,Canada,http://www.isracann.com,86400,595 Burrard Street,Drug Manufacturers—Specialty & Generic,Suite 1600
